Skip to content

Needle-free Dental Anesthesia

Needle-free Dental Anesthesia: a Pilot Split-mouth Cross-over Randomized Clinical Trial.

Status
Suspended
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04493528
Enrollment
30
Registered
2020-07-30
Start date
2019-07-18
Completion date
2023-12-30
Last updated
2021-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Local, Needle Phobia

Keywords

Needle-free injection, Dental anesthesia, Infiltration, Nerve block

Brief summary

Many patients experience pain and anxiety from traditional needle anesthesia and may avoid necessary dental treatments. The needle-free liquid jet injection(NFLJI) could solve these problems. NFLJI delivers drug solutions by creating a micro-thin pressure liquid jet to penetrate the skin and disperse in the soft tissue. It has many advantages like eliminating injection pain, needle phobia and needle disposal. However, anesthesia techniques in dentistry were all developed for needle injection, and they are not very effective for NFLJI. Moreover, clinical trials of dental anesthesia using NFLJI have shown inconsistent efficacy. In this study, we aim to compare the clinical efficacy between NFLJI and needle dental anesthesia in pilot split-mouth cross-over randomized clinical trials, assess the feasibility to conduct such trial on a larger scale. Participants will be assigned to one of the following four groups: 1. Infiltration on a maxillary lateral incisor,2. Inferior alveolar nerve block, 3.Mental nerve block, 4. Infraorbital nerve block. Each participant will receive one injection with a needle and another one with NFLJI randomly at the same appointment. A washout period of 1 hour between two procedures for participants' to forget the previous experience. Needle injection will be performed according to clinical standards. NFLJI will be performed according to a guideline developed in our research group. Participants will stay in the clinic until the anesthesia effect disappear and be followed for one week. The primary outcome is the efficacy and effect of two anesthesia interventions. The secondary outcome is the pain and anxiety visual analogue scale before and during injection, taste preference, and complications. Additionally, patients' overall feelings for two interventions as well as any barriers to conducting such a trial will be recorded.

Interventions

COMBINATION_PRODUCTMeso-Jet, 2% lidocaine(xylocaine)

Performing local dental anesthesia using needle-free liquid jet injection with different parameters (pressure, volume, injection technique). Anesthetic agent: 2% lidocaine with 1:100,000 epinephrine, dose: 0.3-2ml.

COMBINATION_PRODUCTNeedle,2% lidocaine(xylocaine)

Performing local dental anesthesia using syringe and needles, same as regular clinical practice. Anesthestic agent: 2% lidocaine with 1:100,000 epinephrine,dose: 0.3-2ml.

Sponsors

MEDICAL INTERNATIONAL TECHNOLOGIES (MIT CANADA) INC.
CollaboratorUNKNOWN
McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Each participant receive two anesthesia methods randomly. Total 8 arms, 4 groups, each group will recruit 6 participants. Incase of drop out, a total of 30 participant will be enrolled.

Intervention model description

Randomized split-mouth cross-over clinical trial.

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* age between 18-35 years-old * fluent in English * cooperate

Exclusion criteria

* has a history of chronic pain, * has a systematic disease, * has root canal therapy at the upper lateral incisor/lower posterior teeth region.

Design outcomes

Primary

MeasureTime frameDescription
Time to initiation of anesthesia1 minute after injectionTime to initiation of anesthesia feeling, measured by a simple pinch test using a periodontal probe
Time to termination of anesthesia3 hours after injectionTime to termination of anesthesia feeling, measured by a simple pinch test using a periodontal probe
Dental pulp anesthesia10 minutes after injection.Dental pulp anesthesia result is measured by an electric pulp test(EPT), successful anesthesia for dental pulp exhibits an EPT at 80.
Efficacy of dental pulp anesthesia10 minutes after injection.The number of sucessful dental pulp anesthesia cases over total number of participants in the group.

Secondary

MeasureTime frameDescription
Incidence of adverse effect during follow-up period[safety]up to 7 daysIncidence of adverse effect after aneshesia procedure during follow-up period, such as: ulcer, hematoma, discomfort, abnormal feeling, nerve damage.
Anxiety level during injection10 seconds after the injection.Participants' anxiety level when receiving the needle or needle-free injection, measured by visual analogue scale for anxiety.From 0 to 10, 0 stands for Not at all Anxious, 10 stands for Extremely Anxious. Higher score means a worse outcome.
Taste preference1 minute after the injectionParticipants' taste preference after needle or needle-free injection, measured by 9-point hedonic scale for measuring food acceptability. From 1 to 9, 1 stands for dislike extremely, 5 stands for neither like or dislike, 9 stands for like extremely. Higher score means a better outcome.
Incidence of adverse effect [safety]10 seconds after injection.Incidence of adverse effect immediately after aneshesia injection, such as tissue damage, bleeding, hematoma.
Baseline pain level1 minute before injectionParticipants' pain level before receiving the needle or needle-free injection, measured by standard visual analog scale for pain. From 0 to 10, 0 stands for no pain, 10 stands for worst pain. Higher score means a worse outcome.
Pain level during injection10 seconds after the injectionParticipants' pain level when receiving the needle or needle-free injection, measured by standard visual analog scale for pain. From 0 to 10, 0 stands for no pain, 10 stands for worst pain. Higher score means a worse outcome.
Baseline anxiety level1 minute before injectionParticipants' anxiety level before receiving the needle or needle-free injection, measured by visual analogue scale for anxiety. From 0 to 10, 0 stands for Not at all Anxious, 10 stands for Extremely Anxious. Higher score means a worse outcome.

Other

MeasureTime frameDescription
Barriersthrough study completion, from date of recruitment until the date of last follow-up case complition, an average of 6 month.Record possible barriesrs in recruitment,randomization,operation.
Participant's feedbacks20 minutes after all procedures.Reord participants's feedbacks about the whole trial, such as: overall feelings, preferences,complains.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026